All Stories

  1. Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT
  2. A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age
  3. Disease burden of people with uncontrolled severe asthma with and without biomarkers of inflammation
  4. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
  5. Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY
  6. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
  7. Narrative Review: Obesity, Type 2 DM and Obstructive Sleep Apnoea—Common Bedfellows
  8. The burden of disease in people with mild asthma
  9. Frequent productive cough in asthma and/or COPD
  10. Treatable traits in the NOVELTY study
  11. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG
  12. Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women
  13. Pilot study to assess physician compliance in non-invasive ventilation titration based on venous blood gasses versus arterial blood gasses in acute respiratory failure patients
  14. Management of acute COPD exacerbations in Australia: do we follow the guidelines?
  15. The effectiveness of small-bore intercostal catheters versus large-bore chest tubes in the management of pleural disease with the systematic review of literature
  16. Sleep apnoea among Australian Aboriginal and non-Aboriginal patients in the Northern Territory of Australia—a comparative study
  17. Chronic Obstructive Pulmonary Disease In Aboriginal Patients Of The Northern Territory Of Australia: A Landscape Perspective
  18. New cost-effective pleural procedure training: manikin-based model to increase the confidence and competency in trainee medical officers
  19. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
  20. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
  21. Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial
  22. Extended-release morphine for chronic breathlessness in pulmonary arterial hypertension – a randomised, double-blind, placebo-controlled, crossover study
  23. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
  24. Small bore intercostal catheters are as efficient as large bore intercostal tubes with better patient tolerance
  25. Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
  26. Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with...
  27. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
  28. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone
  29. Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
  30. Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
  31. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
  32. Treatment of severe asthma with Mepolizumab monoclonal antibody
  33. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
  34. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients
  35. Pulmonary Hypertension and Right Heart Dysfunction in Chronic Lung Disease
  36. Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia
  37. A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle
  38. Treatment of Pulmonary Arterial Hypertension in a Tertiary Setting
  39. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
  40. Dyspnea in Pulmonary Arterial Hypertension
  41. Pediatric influenza immunization
  42. Management of dyspnea in advanced pulmonary arterial hypertension
  43. Persistent unilateral right diaphragmatic palsy following liver transplantation
  44. Pulmonary toxicity associated with infliximab therapy for ulcerative colitis
  45. Obstructive Sleep Apnea and Pulmonary Hypertension
  46. A 29-Year-Old Man With Pulmonary Complications of a Thrombotic Disorder
  47. Estimation of Pulmonary Artery Pressures in Intensive Care Patients Using Both Continuous and Pulsed Wave Doppler
  48. CPAP therapy improves lung circulation in patients with obstructive sleep apnoea
  49. Daytime Pulmonary Hemodynamics in Patients with Obstructive Sleep Apnea without Lung Disease
  50. In Reply to Dr Barbara Gothe
  51. Portable Computerized Polysomnography in Attended and Unattended Settings
  52. Sleep apnoea related hypoxia is associated with cognitive disturbances in patients with tetraplegia
  53. Comparison of effects of sustained isocapnic hypoxia on ventilation in men and women
  54. A Comparison of Two Long-Acting Vasoselective Calcium Antagonists in Pulmonary Hypertension Secondary to COPD
  55. Pulmonary Hemodynamics and Hypoxemia in Sleep Apnea
  56. Effects of sleep posture on upper airway stability in patients with obstructive sleep apnea.
  57. Does the Route of Local Anesthesia and Insertion Influence Oxygenation in Patients Undergoing Flexible Bronchoscopy?
  58. Sleep apnoea in patients with quadriplegia.
  59. The effects of the GABA agonist, baclofen, on sleep and breathing
  60. Validation of New Pulsed Doppler Echocardiographic Techniques-To the Editor
  61. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome.
  62. Felodipine Improves Pulmonary Hemodynamics in Chronic Obstructive Pulmonary Disease
  63. Validation of New Pulsed Doppler Echocardiographic Techniques for Assessment of Pulmonary Hemodynamics
  64. Neuron specific enolases: diagnostic marker for small cell lung cancer
  65. The level of carcinoembryonic antigen, tissue proliferative antigen and carbonhydratic antigen 19.9 in serum of patients with different hystological types of lung cancer